CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-09 | Mazzo David J President & CEO | Grant or award | +81,000 | 352,986 | ||
| 2026-01-09 | Mazzo David J President & CEO | Shares withheld for taxes | −10,503 | $1.97 | $21K | 342,483 |
| 2026-01-09 | Mazzo David J President & CEO | Shares withheld for taxes | −10,515 | $1.97 | $21K | 331,968 |
| 2026-01-09 | Mazzo David J President & CEO | Shares withheld for taxes | −12,224 | $1.97 | $24K | 319,744 |
| 2026-01-09 | Mazzo David J President & CEO | Shares withheld for taxes | −7,854 | $1.97 | $15K | 311,890 |
| 2026-01-09 | Mazzo David J President & CEO | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-01-09 | AZAB MOHAMMAD Director | Grant or award | +30,456 | 104,925 | ||
| 2026-01-09 | HENSON HEIDI Director | Grant or award | +30,456 | 85,725 | ||
| 2026-01-09 | KLOSK STEVEN M Director | Grant or award | +30,456 | 95,815 | ||
| 2025-01-10 | Nisco James SVP, Fin/Treas, Chief Actg Off | Shares withheld for taxes | −416 | $3.73 | $2K | 23,491 |
| 2025-01-10 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −456 | $3.73 | $2K | 79,794 |
| 2025-01-10 | Mazzo David J President & CEO | Shares withheld for taxes | −3,106 | $3.73 | $12K | 264,690 |
| 2025-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | Grant or award | +15,000 | 27,956 | ||
| 2025-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | Shares withheld for taxes | −2,131 | $3.80 | $8K | 25,825 |
| 2025-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | Shares withheld for taxes | −1,137 | $3.80 | $4K | 24,688 |
| 2025-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | Shares withheld for taxes | −781 | $3.80 | $3K | 23,907 |
| 2025-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2025-01-09 | Buck Kristen K EVP, R&D and CMO | Grant or award | +25,000 | 87,672 | ||
| 2025-01-09 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −2,651 | $3.80 | $10K | 85,021 |
| 2025-01-09 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −2,863 | $3.80 | $11K | 82,158 |
Page 2 of 18 · 345 trades